Clinical Trials

Toll-Free: 866.320.4573

Call Us Toll Free:

866.223.2273 x1234

Coenzyme Q-10 and Pulmonary Arterial Hypertension

Study:

Coenzyme Q-10 in the Treatment of Pulmonary Arterial Hypertension

Rationale:

n/a

Purpose:

The purpose of this study is to evaluate the effects of Coenzyme Q-10, an antioxidant, in the treatment of pulmonary hypertension.

Study Status: Active, not recruiting

Recruiting:
n/a

Condition Intervention Phase
Pulmonary Arterial Hypertension Other: Nutritional Supplement Coenzyme Q-10 N/A

Verified by The Cleveland Clinic December, 2013

Sponsored by: The Cleveland Clinic
Information provided by: The Cleveland Clinic
ClinicalTrials.gov identifier: NCT01148836

Study Type: Interventional

Study Design: Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Cleveland Clinic
Cleveland, Ohio 44195
United States

Jackie Sharp, CNP., Principal Investigator

This information is abridged to display results relevant only to Cleveland Clinic. To see complete record visit ClinicalTrials.gov
  Information obtained from ClinicalTrials.gov on
Link to the current ClinicalTrials.gov record.

Cleveland Clinic Mobile Site